Nov 11, 2026 · 14 min
Scientists test whether cells can turn back their biological clocks
Can scientists reverse your age?
Early human trials are testing whether cellular rejuvenation can treat age-related disease without erasing a cell’s identity, raising larger questions about lifespan.
- 1Epigenetic clocks offer useful but imperfect estimates of biological age and disease risk.
- 2Researchers are testing partial cellular reprogramming in retinal cells as an early treatment for glaucoma.
- 3Animal studies suggest rejuvenation may reach multiple tissues, but extending healthy human lifespan remains uncertain.
Don't miss
Researchers use partial epigenetic reprogramming to make retinal cells younger while preserving their identity, creating an early human test of age reversal.
The brief
Aging changes cells partly by altering epigenetic switches that help preserve identity, but measuring those changes precisely remains difficult.
Commercial biological-age tests offer rough estimates; researchers are developing richer clocks that combine cell types and molecules to predict disease risk.
The eye is an early test case for partial reprogramming: three of four factors may rejuvenate retinal cells without wiping away their identity.
Early human trials and animal studies point toward possible effects in muscle, kidney, nerve, immune, and memory systems, though major questions remain.
The central uncertainty is whether treating age-related diseases would merely extend healthier years or eventually add decades to human life.
Weekly email
State of the Pod, every Monday
The week's most-discussed names and stories from podcasts, with the moments behind them. Free, five minutes, unsubscribe in one click.